Obsah

Neutrophil-to-lymphocyte ratio as a prognostic biomarker for men with metastatic castration-resistant prostate cancer receiving first-line chemotherapy: data from two randomized phase III trials

Autor: van Soest, R.J. *, ‡, Templeton, A.J. , Vera-Badillo, F.E., Mercier, F., Sonpavde, G., Amir, E., Tombal, B., Rosenthal, M., Eisenberger, M.A., Tannock, I.F., de Wit, R.
Zdroj: In Annals of Oncology April 2015 26(4):743-749
Databáze: ScienceDirect
Popis
ISSN:09237534
DOI:10.1093/annonc/mdu569